<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04585360</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A01819-48</org_study_id>
    <nct_id>NCT04585360</nct_id>
  </id_info>
  <brief_title>Psychiatric Manifestations Associated With Behcet's Disease</brief_title>
  <acronym>PSYCHO-B7</acronym>
  <official_title>Psychiatric Manifestations Associated With Behcet's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The psychoBehçet'study is aimed at evaluating the psychological and neurocognitive symptoms&#xD;
      in 25 consecutive patients followed for Behçet's disease. This is a monocentric,&#xD;
      observational, non interventional study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be evaluated during a day-care facility for Behçet's disease activity together&#xD;
      with evaluation of anxiety and depression symptoms (SCL90-R and MINI assessments), fatigue&#xD;
      (MFI) and quality of life (SF36).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 10, 2020</start_date>
  <completion_date type="Anticipated">February 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SCL90-R questionnaire</measure>
    <time_frame>Inclusion visit</time_frame>
    <description>Anxiety/depression symptoms questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MINI questionnaire</measure>
    <time_frame>Inclusion visit</time_frame>
    <description>Anxiety/depression symptoms questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MFI questionnaire</measure>
    <time_frame>Inclusion visit</time_frame>
    <description>Tiredness assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF36 questionnaire</measure>
    <time_frame>Inclusion visit</time_frame>
    <description>Quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BSAS/BDCAF evaluation</measure>
    <time_frame>Inclusion visit</time_frame>
    <description>Behçet's disease activity</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Behçet's Disease, neuroBehcet, Anxiety, Depression, Tiredness</condition>
  <arm_group>
    <arm_group_label>Patient with Behcet disease</arm_group_label>
    <description>adult patient with Behcet's disease followed regularly in the internal medicine department of Bicetre</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires evaluating anxiety and depression symptoms, tiredness, and quality of life</intervention_name>
    <description>Realization of specific questionnaires evaluating:&#xD;
psychiatric symptoms (self-assessment according to the SLC-90R questionnaire and hetero-assessment by the internist doctor of the center according to the M.I.N.I. questionnaire)&#xD;
fatigue (Multidimensional Fatigue Inventory (MFI-20), French version, in self-assessment)&#xD;
quality of life (SF36 self-assessment questionnaire)</description>
    <arm_group_label>Patient with Behcet disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patient regularly monitored in the internal medicine department of Bicêtre&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult male or female&#xD;
&#xD;
          -  Regular follow-up in the internal medicine department of Bicetre hospital&#xD;
&#xD;
          -  Diagnosed with Behçet's disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to participate in the study&#xD;
&#xD;
          -  Poor command of the French language&#xD;
&#xD;
          -  Patients under legal protection&#xD;
&#xD;
          -  Pregnant woman&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>NOEL NN Nicolas, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP, Hôpital Bicetre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicolas NN NOEL, MD PhD</last_name>
    <phone>+ 33 1 45 21 27 57</phone>
    <email>nicolas.noel@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fanny FU URBAIN, MD</last_name>
    <phone>+ 33 1 45 21 27 57</phone>
    <email>fanny.urbain@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Internal medecine department</name>
      <address>
        <city>Le Kremlin-Bicetre</city>
        <state>Val De Marne</state>
        <zip>94275</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Nicolas NOEL, MD, PhD</last_name>
      <phone>+ 331 45 21 27 57</phone>
      <email>nicolas.noel@aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Fanny URBAIN, MD</last_name>
      <phone>+ 33 1 45 21 27 57</phone>
      <email>fanny.urbain@aphp.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>October 9, 2020</study_first_submitted>
  <study_first_submitted_qc>October 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2020</study_first_posted>
  <last_update_submitted>October 9, 2020</last_update_submitted>
  <last_update_submitted_qc>October 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Behcet Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

